Aura Biosciences (AURA) Free Cash Flow (QoQ) (2021 - 2026)
Aura Biosciences (AURA) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.31% |
| Dec 31, 2025 | -2.05% |
| Sep 30, 2025 | 3.86% |
| Jun 30, 2025 | 10.08% |
| Mar 31, 2025 | 9.09% |
| Dec 31, 2024 | -72.98% |
| Sep 30, 2024 | 6.83% |
| Jun 30, 2024 | 35.13% |
| Mar 31, 2024 | -42.71% |
| Dec 31, 2023 | -10.01% |
| Sep 30, 2023 | -7.58% |
| Jun 30, 2023 | 11.94% |
| Mar 31, 2023 | 5.36% |
| Dec 31, 2022 | -57.70% |
| Sep 30, 2022 | -3.04% |
| Jun 30, 2022 | 30.74% |
| Mar 31, 2022 | -38.91% |
| Dec 31, 2021 | -20.54% |
| Sep 30, 2021 | -29.39% |
| Jun 30, 2021 | -37.46% |